MIR1184-3: A Drug Target / Disease Biomarker (G100422977)
MIR1184-3: A Drug Target / Disease Biomarker
MIR1184-3 is a protein that is expressed in various tissues of the body, including the brain, lungs, heart, kidneys, and gastrointestinal tract. It is a member of the Mir gene family, which encodes for a family of transmembrane proteins that play important roles in various cellular processes. One of the most well-studied proteins in the Mir family is MIR1184-2, also known as CD11b, which is a high-affinity receptor for integrins, a family of transmembrane proteins that play a central role in cell-cell and cell-extracellular matrix interactions. MIR1184-3, like MIR1184-2, is a potential drug target or biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
MIR1184-3 is involved in several cellular processes that are critical for normal physiological function. One of its most well-studied functions is its role in cell adhesion and migration. MIR1184-3 is a critical receptor for the protein Integrin 伪6 (ITGA6), which is involved in the formation of tight junctions, which are a type of cell-cell adhesion that is critical for various physiological processes, including cell signaling and tissue structure. MIR1184-3 is also involved in the regulation of cell migration, which is critical for the development and progression of tissues and organs during development and adults.
In addition to its role in cell adhesion and migration, MIR1184-3 is also involved in the regulation of inflammation and immune responses. MIR1184-3 is a strong predictor of the transition of human keratinocytes from a non-invasive to an invasive form of skin cancer, a condition that is characterized by the development of tumors on the skin. MIR1184-3 is also involved in the regulation of inflammation and immune responses, including the regulation of T cell responses to infection.
MIR1184-3 is also a potential biomarker for several diseases, including cancer. The high-affinity receptor for integrins, as described by MIR1184-2, makes it an attractive target for cancer therapies that target the regulation of integrin function. For example, inhibitors of the integrin 伪6 receptor, such as those used in chemotherapy, have been shown to enhance the effectiveness of various cancer treatments. In addition, MIR1184-3 has been shown to be involved in the regulation of angiogenesis, which is the process by which tumors grow and recruit blood vessels to feed their growth. Therefore, MIR1184-3 may be a useful biomarker for cancer diagnosis and treatment.
MIR1184-3 is also a potential drug target for neurodegenerative diseases. The regulation of integrin function by MIR1184-2 and MIR1184-3 is involved in several neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. These conditions are characterized by the progressive loss of brain cells and the accumulation of neurofibrillary tangles and other abnormally structured proteins in the brain. MIR1184-3 may be a potential target for therapies that aim to slow down or reverse the progression of these conditions.
In addition to its potential uses in cancer and neurodegenerative diseases, MIR1184-3 may also be a useful biomarker for autoimmune disorders. The regulation of integrin function by MIR1184-2 and MIR1184-3 is involved in the development and regulation of autoimmune diseases, including rheumatoid arthritis, lupus, and multiple sclerosis. These conditions are characterized by the immune system attacking the body's own tissues, leading to inflammation and damage. MIR1184-3 may be a potential target for therapies that aim to slow down or reverse the progression of these conditions.
In conclusion, MIR1184-3 is a protein that is involved in several cellular processes that are critical for normal physiological function. Its role in cell adhesion and migration, as well as its involvement in the regulation of inflammation and immune responses, makes it an attractive target for drug development. The high-affinity receptor for integrins, as described by MIR1184-2, makes it an attractive target for cancer therapies, as does its involvement in the regulation of angiogenesis and the development of neurodegenerative diseases. In addition, MIR1184-3 may also be a useful biomarker for autoimmune disorders. Further research is needed to fully understand the role of MIR1184-3 in these diseases and to develop effective therapies that target its function.
Protein Name: MicroRNA 1184-3
More Common Targets
MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2
